MENU

CTSO Stock Cytosorbents (CTSO, $0.89) Moving Average Convergence Divergence (MACD) Histogram turned negative on June 6, 2024

A.I.dvisor
at Tickeron.com
06/07/24
Loading...
CTSO - Cytosorbents Corp
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $0.8859
Daily change: -$0.0441 (-4.74%)
Daily volume: 56.1K
Capitalization: $48.1M
Industry: Medical Specialties
This is a Bearish indicator signaling CTSO's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 46 similar cases where CTSO's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

CTSO's Stochastic Oscillator entering overbought zone

The Stochastic Oscillator for CTSO moved into overbought territory on November 14, 2024. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 25, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CTSO as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CTSO entered a downward trend on November 14, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CTSO's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CTSO just turned positive on November 13, 2024. Looking at past instances where CTSO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSO advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

CTSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.115) is normal, around the industry mean (22.930). P/E Ratio (0.000) is within average values for comparable stocks, (83.945). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.605). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.302) is also within normal values, averaging (43.286).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
CTSO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of products to support healthcare professionals in the treatment of complex medical conditions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
305 College Road East
Phone
+1 732 329-8885
Employees
186
Web
https://www.cytosorbents.com